Skip to main content

Peer Review reports

From: Prognostic biomarkers to identify patients destined to develop severe Crohn’s disease who may benefit from early biological therapy: protocol for a systematic review, meta-analysis and external validation

Original Submission
6 Jul 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
14 Nov 2016 Editorially accepted
1 Dec 2016 Article published 10.1186/s13643-016-0383-5

You can find further information about peer review here.

Back to article page